Risk factors and treatment for obstructive sleep apnea amongst obese children and adults

Mark Kohler1

  • 1Discipline of Paediatrics, University of Adelaide, Women's and Children's Hospital, South Australia, Australia. mark.kohler@adelaide.edu.au

Insights

Obesity is linked to obstructive sleep apnea (OSA), with factors like age and anatomy influencing risk. Weight-loss strategies show promise for treating OSA in obese individuals.

Area of Science:

  • Sleep Medicine
  • Obesity Research
  • Respiratory Health

Background:

  • Obesity is a growing global health concern.
  • Obstructive sleep apnea (OSA) is a common sleep disorder.
  • The relationship between obesity and OSA requires further investigation.

Purpose of the Study:

  • To review evidence on the association between obesity and OSA.
  • To identify risk factors for OSA in obese patients.
  • To summarize treatment strategies for OSA in obese individuals.

Main Methods:

  • Systematic literature review.
  • Analysis of recent research findings.
  • Synthesis of evidence on predisposing factors and treatments.

Main Results:

  • Obesity predisposes individuals to OSA through factors like sex, age, upper airway structure, and ethnicity.
  • Weight-reduction strategies, both invasive and noninvasive, are effective in managing OSA in obese adults and children.
  • The direct association between body mass and airway obstruction needs cautious interpretation.

Conclusions:

  • Obesity's role in OSA predisposition varies among subgroups, particularly adults with specific craniofacial morphology.
  • Standard OSA treatments may be less effective in obese patients.
  • Weight-reduction strategies are crucial for optimal OSA management in obese individuals, with invasiveness tailored to patient needs.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...